Rakuten Investment Management Inc. Makes New Investment in Ventas, Inc. $VTR

Rakuten Investment Management Inc. acquired a new stake in Ventas, Inc. (NYSE:VTRFree Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 152,949 shares of the real estate investment trust’s stock, valued at approximately $10,705,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. True Wealth Design LLC lifted its stake in Ventas by 1,557.7% during the third quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust’s stock worth $30,000 after purchasing an additional 405 shares during the last quarter. Wilmington Savings Fund Society FSB increased its stake in Ventas by 65.5% in the third quarter. Wilmington Savings Fund Society FSB now owns 455 shares of the real estate investment trust’s stock valued at $32,000 after purchasing an additional 180 shares during the last quarter. ORG Partners LLC raised its holdings in Ventas by 76.1% during the third quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust’s stock worth $32,000 after purchasing an additional 197 shares in the last quarter. Ameritas Advisory Services LLC purchased a new stake in shares of Ventas during the 2nd quarter worth approximately $33,000. Finally, Golden State Wealth Management LLC lifted its position in shares of Ventas by 52.7% during the 2nd quarter. Golden State Wealth Management LLC now owns 536 shares of the real estate investment trust’s stock worth $34,000 after buying an additional 185 shares during the last quarter. Institutional investors and hedge funds own 94.18% of the company’s stock.

Wall Street Analysts Forecast Growth

VTR has been the topic of a number of recent analyst reports. Jefferies Financial Group reaffirmed a “buy” rating and issued a $93.00 target price on shares of Ventas in a research report on Monday, December 15th. Scotiabank upped their price objective on shares of Ventas from $74.00 to $80.00 and gave the company a “sector perform” rating in a research note on Thursday, November 13th. Citigroup lifted their target price on Ventas from $80.00 to $88.00 and gave the stock a “buy” rating in a research report on Tuesday, November 11th. Wells Fargo & Company boosted their target price on Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a report on Tuesday, November 25th. Finally, KeyCorp upped their target price on Ventas from $70.00 to $85.00 and gave the company an “overweight” rating in a research report on Thursday, December 4th. Fourteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $81.63.

Get Our Latest Stock Report on Ventas

Ventas Trading Down 0.6%

NYSE VTR opened at $77.74 on Thursday. The firm’s fifty day moving average is $78.54 and its two-hundred day moving average is $72.16. Ventas, Inc. has a one year low of $58.22 and a one year high of $81.89. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.32 and a current ratio of 0.32. The firm has a market cap of $36.52 billion, a PE ratio of 149.51, a P/E/G ratio of 1.93 and a beta of 0.78.

Ventas (NYSE:VTRGet Free Report) last announced its earnings results on Wednesday, October 29th. The real estate investment trust reported $0.88 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.01. Ventas had a net margin of 4.28% and a return on equity of 2.05%. The business had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.44 billion. During the same quarter in the prior year, the firm earned $0.80 earnings per share. The business’s quarterly revenue was up 20.5% compared to the same quarter last year. Ventas has set its FY 2025 guidance at 3.450-3.480 EPS. Analysts expect that Ventas, Inc. will post 3.4 earnings per share for the current year.

Ventas Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, January 15th. Shareholders of record on Wednesday, December 31st were paid a $0.48 dividend. This represents a $1.92 annualized dividend and a dividend yield of 2.5%. The ex-dividend date was Wednesday, December 31st. Ventas’s dividend payout ratio (DPR) is 369.23%.

Insider Buying and Selling at Ventas

In related news, CEO Debra A. Cafaro sold 317,258 shares of the stock in a transaction on Thursday, October 30th. The stock was sold at an average price of $74.24, for a total transaction of $23,553,233.92. Following the completion of the sale, the chief executive officer directly owned 1,145,695 shares of the company’s stock, valued at $85,056,396.80. This trade represents a 21.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Peter J. Bulgarelli sold 3,924 shares of the business’s stock in a transaction on Tuesday, November 4th. The shares were sold at an average price of $75.00, for a total transaction of $294,300.00. Following the completion of the transaction, the chief executive officer directly owned 112,564 shares in the company, valued at $8,442,300. This represents a 3.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 494,005 shares of company stock worth $37,132,767. 0.80% of the stock is currently owned by insiders.

About Ventas

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

See Also

Institutional Ownership by Quarter for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.